U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230912) titled 'Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes' on Oct. 02.
Brief Summary: * Assess response to treatment in children with bronchial asthma attending Assiut university children hospital.
* Role of comorbidities in controlling symptoms of bronchial asthma.
* Evaluate the role of the soluable interleukin 5 receptor, I C-telopeptide of type I collagen (ICTP), miR-223-3p and miR-191-5p in bronchial asthma.
Study Start Date: Dec. 30
Study Type: OBSERVATIONAL
Condition:
Bronchial Asthma
Intervention:
DRUG: Short Acting Beta 2 Agonist
short acting drug
Recruitment Status: NOT_YET_RECRUITING
Sp...